Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Healthy: early-phase trial registry
225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2 of 28,963 conditions by registered trial count.
1,096 US clinical trials · 225 currently recruiting · #2 of 28,963 conditions by registered trial count
Healthy: 1,096 US clinical trials tracked, 225 recruiting.
Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.
Open enrollment, early-phase tilt
Healthy has 1,096 registered US clinical trials, 225 of them open to new participants right now, about 21% of the total.
- 225
- recruiting participants now
- 21%
- of trials open to enrollment
- 43
- in Phase 3-4 (later-stage)
- 55
- top sponsor: Eli Lilly and Company
Corpus placement: #2 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.
Key findings
What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.
-
Healthy is recruiting below its size-band peers.
225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Healthy trials is spread across many organizations.
Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.
-
Most Healthy trials plan to enrol fewer than 100 people.
Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.
-
Healthy research is mostly interventional.
905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
1,096 total, page 18 of 22
Pasta Formulations, Portion Sizes and Their Effect on Appetite
Clinical Nutrition Research Center, Illinois Institute of Technology
NCT01199770
Fed Study of Oxybutynin Chloride Extended-release Tablets 10 mg and Ditropan XL® Tablets 10 mg
Mylan Pharmaceuticals
NCT00649727
DSM265 Prophylaxis of Plasmodium Falciparum Malaria
Medicines for Malaria Venture
NCT02562872
Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches
Scilex Pharmaceuticals
NCT05106400
A Study of Doravirine and Islatravir as a Single Entity or Combination Therapy and the Effect of Food in Healthy Adult Participants (MK-8591A-055)
Merck Sharp & Dohme
NCT06719570
Azithromycin 600 Mg Tablets, Fed
Teva Pharmaceuticals U
NCT00834132
Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects
Scilex Pharmaceuticals
NCT04319926
PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function
Pharmaceutical Project Solutions
NCT02775955
Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg
Mylan Pharmaceuticals
NCT00647673
PET Scans in Normal Volunteers and Patients With Fabry Disease
National Institute of Neurological Disorders and Stroke (NINDS)
NCT00005111
Multiple Dose Safety Study of SRX246 Capsules in Healthy Volunteers
Azevan Pharmaceuticals
NCT01088932
Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg
Mylan Pharmaceuticals
NCT00648063
Investigation of the Pharmacokinetic Profile of CBD - Phase 1 ANANDA
Icahn School of Medicine at Mount Sinai
NCT05023070
Safety and Tolerability of STP206 in Healthy Adult Subjects
Leadiant Biosciences
NCT00922324
A Clinical Study to Assess the Effect of Enlicitide on How the Body Processes Digoxin in Healthy Adult Participants (MK-0616-031)
Merck Sharp & Dohme
NCT06597760
Bioavailability Study of K0706 in Healthy Subjects
Sun Pharma Advanced Research Company Limited
NCT03316820
Dose Proportionality of TFV-DP After a Single Dose of GS-7340 in Women
University of North Carolina, Chapel Hill
NCT02357602
Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure
Allergan
NCT01089062
Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions.
Dr. Reddy's Laboratories Limited
NCT01131897
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB
National Institute of Mental Health (NIMH)
NCT00527579
Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions
Teva Pharmaceuticals U
NCT00974012
Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg
Mylan Pharmaceuticals
NCT00649038
Pre-Workout on Exercise Performance and Cognition
Miami Research Associates
NCT02255201
A Wearable System to Monitor Tai Chi Practice
Spaulding Rehabilitation Hospital
NCT01687023
A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT01186588
Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers
Endocyte
NCT01748864
Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans
Robert J Noveck, M.D.
NCT02789241
Flavanol Absorption, Metabolism and Excretion From Fruit-based Drinks and Other Food Matrixes
University of California, Davis
NCT03526094
Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment
Ensoma
NCT04154670
Assessment of Endogenous Oxalate Synthesis
University of Alabama at Birmingham
NCT05229952
Dose-dependent Identification of Unique Biomarkers
San Diego State University
NCT05600348
Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.
Teva Pharmaceuticals U
NCT00840216
Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions
Teva Pharmaceuticals U
NCT00833664
Effects of Drugs on Responses to Brain and Emotional Processes
University of Chicago
NCT04053036
Calcium Retention as Influenced by Dietary Components That Induce an Acid Load
USDA Grand Forks Human Nutrition Research Center
NCT00620763
Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects
Liminal BioSciences
NCT03637049
Effects of Systemically Administered Hydrocortisone on the Immune System in Healthy Volunteers
National Heart, Lung, and Blood Institute (NHLBI)
NCT01281995
Optical Head-Mounted Display Technology for Low Vision Rehabilitation
University of Michigan
NCT02983305
Neck Cooling as a Non-Invasive Method to Lower Brain Temperature in Healthy Adults
University of Vermont
NCT04973085
An Open-Label Food Effect Study of Telotristat Etiprate
Lexicon Pharmaceuticals
NCT02157584
Effects of Liothyronine on Energy Expenditure and Cardiovascular Function
Virginia Commonwealth University
NCT03098433
Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers
University of Arizona
NCT00619060
A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics
Adrian Vella
NCT04466566
To Determine the Metabolomics and Microbiome Changes After Cranberry Juice Consumption Among Young Women
University of Florida
NCT02860468
Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg
Mylan Pharmaceuticals
NCT00648856
Glycemic Response of Whole Beans and Bean Products
Iowa State University
NCT06630312
Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole
Purdue Pharma
NCT01259115
The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers
AstraZeneca
NCT00985933
Study to Assess Effect of Cyclosporine on the Blood Levels of Ticagrelor
AstraZeneca
NCT01504906
Evaluation of the Antioxidant and Anti-Inflammatory Capacities of the 'Rosy Red Valencia' and 'Olinda Valencia' Sweet Orange Varieties in Healthy Subjects
University of California, Davis
NCT06944210
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 518 |
| Phase 2 | 28 |
| Phase 3 | 11 |
| Phase 4 | 32 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
What is open for Healthy right now
225 recruiting of 1,096 indexed (21% open).
Phase mix: 43 late (III/IV) vs 546 early (I/II) (early-phase heavy).
Top sponsor: Eli Lilly and Company (55 trials), 9 others listed. 50 shown below, recruiting first. #2 of 28,963 conditions by registered trial count.
How open-enrollment share is computed
Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.
Frequently Asked Questions
How many clinical trials are there for Healthy?
PlainTrial tracks 1,096 US clinical trials for Healthy, of which 225 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Healthy?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.